Please download the abstract submission form at the bottom of the screen and send the completed form to program-111jsp[A]convention[D]co[D]jp ( Please change [A] to @ and [D] to . ) by E-mail.
Information required for abstract submission
The first author from domestic institutions must be a member of the Japanese Society of Pathology. Authors who submit abstract from international institutions are not necessary to be a member of the society.
* Except "Poster presentation - Undergraduate (Undergraduate students)"
(Those who are applying for membership must enter "99" in the "Membership Number" box.)
Inquiries regarding membership can be obtained at the Secretariat Office of the Japanese Society of Pathology. The details of the contact can be found at the bottom of this page.
|September 2 –||October 2, 2021 JST|
1. Presentation style
|• Oral presentation|
|• Poster presentation|
|• Poster presentation（Undergraduate students）|
|• Poster presentation（Trainees）|
|• Poster presentation (Postgraduate students・Residents)|
Please note that we may ask you to present in a different presentation style from your preferred at the time of abstract acceptance.
2. Keywords *required
|Keywords 1 *|
|01||Diagnostic pathology・Human pathology|
|Keywords 2 *|
|03||Oral cavity・Head and neck・Salivary glands|
|08||Serosal membranes・Mesothelium・Somatic cavity|
|09||Upper gastrointestinal tract|
|10||Lower gastrointestinal tract|
|17||Male reproductive organs|
|18||Female reproductive organs|
|19||Placenta and perinatal pathology|
|21||Central nervous system|
|22||Peripheral nervous system|
|23||Bone and soft tissue・Locomotor organs|
|Keywords 3-1 *|
|04||Chronic progressive diseases|
|05||Circulatory failure・Circulatory disturbance|
|06||Metabolic disorder・Degenerative disorder|
|08||Intractable and rare diseases|
|09||Congenital disorder・Developmental anomaly|
|15||Immunohistochemistry・Diagnostic molecular pathology|
|16||Classification of Diseases|
|17||Evaluation of treatment effects・Therapeutic strategies|
|19||Image analysis・AI・Digital pathology|
|24||Chromosomal abnormality・Hereditary diseases|
|25||Animal disease models|
|26||Genetic risks・Environmental factors|
|29||Signal transduction・Cell proliferation・Cell cycle|
|30||Cell death・Cell damage・Senescence|
|31||Invasion and metastasis|
|32||Cancer microenvironment・Cancer stem cells|
|33||Cancer cellular characteristics|
|35||Diagnostic markers・Tumor markers・New therapies|
|36||Cell biology・Molecular imaging|
|37||Cell differentiation・Regenerative medicine|
|38||Development and developmental abnormalities|
|41||Novel technology・Experimental technique|
|Keywords 3-2 for Second Choice (The same keywords as Keywords 3-1)|
The title must be written in English.
Maximum number of letters: 100
*Titles with more than 100 letters cannot be registered.
4. Abstract (main text)
Abstract will be accepted in English only.
Maximum number of letters: 1040
5. Co-author(s) / affiliation(s)
Co-author(s): up to 10 persons including the first author Affiliation(s): up to 10 institutions List of abbreviations used for affiliations: here
6. Selection of abstracts
Submitted abstracts will be peer-reviewed, and acceptance and presentation style will be decided by the program committee.
Notifications of accepted abstract will be sent by e-mail to the authors.
Abstract Submission Form
Please download the abstract submission form and send the completed form to program-111jsp[A]convention[D]co[D]jp ( Please change [A] to @ and [D] to . ) by E-mail.
Inquiries regarding abstract submission
Submission Desk of the 111th Annual Meeting of the Japanese Society of Pathology
c/o Japan Convention Services, Inc.
E-mail: program-111jsp[A]convention[D]co[D]jp ( Please change [A] to @ and [D] to . )